ESC 365 - New target for chemotherapy-induced cardiac dysfunction

Delegates Premium Access

New target for chemotherapy-induced cardiac dysfunction

Session: Basic and translational cardio-oncology beyond anthracyclines

Topic: Diagnosis and Management of Cardiovascular Disease in Patients with Cancer

Speaker: Mr H. Nordin (Paris, FR)

Event: ESC Cardio-Oncology 2025

Congress Presentation

Add to my library

About the speaker

Mr Hugo Nordin

Paris (France)

0 follower

9 more presentations in this session

Gut microbiome correlations with cardiotoxicity biomarkers (LV-GLS, LVEF, Troponin I, NTproBNP) in breast cancer patients prior to chemotherapy

Speaker: Doctor A. Antoniades (Limassol, CY)

Myocardial expression of immune checkpoint molecules in patients with advanced heart failure

Speaker: Doctor T. Gergely (Budapest, HU)

The functional role of TOP2beta PARylation in myeloid cells senescence-associated secretory phenotype (SASP) and atherosclerosis induction following ionizing radiation

Speaker: Professor J. Abe (Houston, US)

Direct effects of the tyrosine kinase inhibitors (TKIs) nilotinib and imatinib on the myocardium: clues towards cardiotoxic profiles

Speaker: Ms Y. Appels (Rotterdam, NL)

HRASV12G overexpression as a driver of senescence in human cardiac fibroblasts

Speaker: Doctor A. Costa (Genoa, IT)

Access the full session

Basic and translational cardio-oncology beyond anthracyclines

Speakers: Mr H. Nordin, Doctor A. Antoniades, Doctor T. Gergely, Professor J. Abe, Ms Y. Appels...

About the event

ESC Cardio-Oncology 2025

20 June - 21 June 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources